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Abstract 
Background: Most malarious countries outside of Africa are co-endemic for Plasmodium falciparum and Plasmo-
dium vivax. The comparative burden of anaemia in the community caused by these two species is incompletely 
characterized.
Methods: A three-stage, cross-sectional, community survey was used to determine the proportion of moderate or 
severe anaemia (haemoglobin <7 g/dL) attributable to patent P. vivax, P. falciparum and mixed parasitaemia in Papua, 
Indonesia. Adjusted population-attributable fractions were calculated from multivariable logistic regression models. 
Eight hundred and twenty-five households were surveyed with a total of 5255 occupants, 3890 (74 %) of whom were 
present and provided a blood sample. Plasmodium falciparum parasitaemia was present in 8.1 % (n = 315) of par-
ticipants, P. vivax in 6.4 % (n = 250) and mixed infections in 1.9 % (n = 72). Overall, P. falciparum was associated with 
a mean reduction in haemoglobin of 1.16 g/dL compared to those without patent parasitaemia [95 % confidence 
interval (95 % CI) 0.91, 1.41 g/dL]. The corresponding values for P. vivax and mixed infections were 0.66 g/dL (95 % CI 
0.35, 0.96) and 1.25 g/dL (0.71, 1.80), respectively. Overall, 16.7 % (95 % CI 8.52, 24.2 %) of haemoglobin concentra-
tions <7 g/dL in the community were estimated to be attributable to patent parasitaemia. The fractions for infants 
and 1–5 years old were 34.4 % (95 % CI −3.30, 58.3 %) and 23.2 % (95 % CI 3.34, 39.0 %), respectively. Plasmodium 
vivax was associated with a greater than threefold higher attributable fraction of anaemia in infants compared with P. 
falciparum [27.6 % (95 % CI −3.20, 49.2 %) versus 7.94 % (−5.87, 20.0 %)].
Conclusion: Despite comparatively low-level endemicity, malaria is associated with a significant proportion of all 
cases of community anaemia in southern Papua. Contrary to its benign reputation, P. vivax is an important and pre-
ventable risk factor for anaemia during infancy—a probable consequence of relapsing disease prior to the develop-
ment of immunity.
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Background
Anaemia is a common manifestation of Plasmodium 
infection [1, 2]. Its impact is most apparent in the hospi-
tal setting where it accounts for a substantial proportion 
of malaria morbidity and, to a lesser extent, mortality 
[3–6].
The burden of malarial anaemia outside of healthcare 
facilities is less well understood and its contribution 
to ‘indirect’ malaria morbidity and mortality is largely 
unknown [7]. There are two major explanations for this 
uncertainty. Firstly, the adverse effects of mild or mod-
erate anaemia per se are not clearly understood. Hae-
moglobin concentrations below 7  g/dL probably confer 
an increased risk of poor pregnancy outcomes such as 
haemorrhagic shock [5], low birth weight [8, 9] and poor 
neurocognitive development [10, 11] but other, less tan-
gible, effects such as decreased resilience to infectious 
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diseases [11] remain unproven. Secondly, in hyper- and 
holo-endemic regions, the majority of individuals will be 
parasitized at any point in time, making it difficult to dis-
entangle the impact of malaria from other concomitant 
causes of anaemia. To get around this problem, research-
ers in highly endemic settings have typically limited their 
assessments to individuals with clinical malaria, based 
on the presence of fever and a probabilistic cut-off for 
parasite density [12, 13]. This approach inevitably misses 
the haematological effects of low-density symptomatic 
infections and asymptomatic parasitaemia. Evidence for 
the likely importance of the latter comes from several 
sources, including intervention trials that have demon-
strated much greater improvements in haemoglobin con-
centrations and mortality than could have been predicted 
by preventing symptomatic infections alone [14–16], as 
well as observational studies showing large variations in 
haemoglobin levels coinciding with seasonal fluctuations 
in parasite prevalence [17]. These and other findings 
led Molineaux to suggest that ‘total’ falciparum malaria 
mortality in Africa is likely to be twice as high as ‘direct’ 
malaria mortality [18]. Although there is relatively little 
information for Plasmodium vivax, one could assume 
that the ratio for this species would be even greater since 
direct deaths are rare (but under-estimated [4, 19–21]) 
and infections are associated with significant morbid-
ity [1, 22–27]. The authors of the current study postulate 
that anaemia, caused by either P. falciparum or P. vivax, 
may underlie a substantial proportion of all ‘indirect’ 
malaria morbidity and mortality.
Southern Papua, like much of south Asia and Latin 
America, is co-endemic for P. falciparum and P. vivax. 
It has a lower entomological inoculation rate than most 
tropical African nations [one to four infective bites per 
year (unpublished data)] but a disproportionately high 
direct malaria-attributable mortality rate [19]. Such a 
setting provides an opportunity to establish the com-
bined haematological impact of both symptomatic and 
asymptomatic parasitaemia since at any point in time the 
majority of the population can be expected to be apara-
sitaemic [28]. Moreover, the similar incidence of P. falci-
parum and P. vivax infections enables valid comparisons 
between the two species. In this study, a cross-sectional, 
community prevalence survey in southern Papua was 
used to determine adjusted fractions of moderate or 
severe anaemia (haemoglobin <7  g/dL) attributable to 
patent P. falciparum, P. vivax and mixed parasitaemia.
Methods
Study site
The geography, climate and demographics of Mimika 
District and its capital city, Timika, have been described 
elsewhere [19, 22, 28]. A census in 2004 estimated the 
local population to be 130,000. Malaria in the region is 
restricted to lowland areas where it is associated with 
three mosquito vectors: Anopheles koliensis, Anopheles 
farauti and Anopheles punctulatus. The annual incidence 
of clinical or asymptomatic malaria is approximately 
876 episodes per 1000 people, 46 % due to P. falciparum 
and 39 % due to P. vivax [28]. Given its equatorial loca-
tion, the climate in Timika does not change significantly 
throughout the year and malaria transmission is peren-
nial. At the time of the survey, patients with uncompli-
cated malaria were generally treated with chloroquine 
plus sulfadoxine-pyrimethamine, or chloroquine alone. 
High rates of resistance to these antimalarials are present 
in both P. falciparum and P. vivax isolates in the region 
and therefore both regimens were abandoned in favour of 
artemisinin-based combination therapy shortly after this 
survey was conducted. A 14-day course of primaquine 
was encouraged for those with vivax malaria, however 
administration was unsupervised.
Cross‑sectional survey methods
Households for this survey were chosen by cluster ran-
dom sampling. First, the four largest of the 12 sub-dis-
tricts in Mimika were chosen purposively. Second, the 
number of clusters required in each sub-district was 
apportioned according to the relative populations of the 
sub-districts. In most cases, clusters constituted discrete 
villages, however, in Mimika Baru the very large popula-
tion size dictated that villages within this sub-district be 
sub-divided into census blocks. Once mapped, clusters 
and 25 houses within each cluster were chosen randomly 
according to WHO recommendations [29]. Household 
members were defined as people who lived under one 
roof, ate from one kitchen and who had resided in the 
study area for at least 6 months. There were no exclusion 
criteria. Sociodemographic information, self-reported 
pregnancy status and history of fever were recorded for 
all household members using a standardized question-
naire. For household members that were not present at 
the time of the survey, this information was collected 
from the head of the household. Those present at the 
time of the survey each had a single weight measurement 
using a uniscale. Axillary temperature was recorded 
using a digital thermometer and a finger-prick sample 
of blood taken for blood film examination and haemo-
globin measurement. Patients with microscopically con-
firmed malaria were treated according to the Indonesian 
Ministry of Health Guidelines. Those with anaemia were 
given iron supplementation according to local protocols. 
The survey was carried out between July and December 
2005.
Page 3 of 10Kenangalem et al. Malar J  (2016) 15:321 
Laboratory methods
Blood films were read locally by certified microscopists 
with at least 10 years experience. A thick smear was con-
sidered negative on initial review if no parasites were 
seen in 100 high power fields. A thin smear was also 
examined to confirm parasite species and used for quan-
tification if parasitaemia was greater than 200 per 200 
WBC. Upon cross-checking 200 high power fields were 
checked before slides were considered negative. Parasi-
taemias were calculated assuming a white cell count of 
7300  cells/µL. All positive films and 10  % of the nega-
tive slides were crosschecked at the National Institute of 
Health Research and Development reference laboratory 
in Jakarta. Results that differed were reviewed by the two 
lead microscopists for final assessment. Haemoglobin 
concentrations were determined using a calibrated port-
able Hemacue® machine.
Statistical analyses
All analyses were done in STATA® version 10.1 (Stata-
Corp, College Station, TX, USA). The primary outcomes 
in this study were: the absolute haemoglobin concentra-
tion, the odds of moderate or severe anaemia and the 
population-attributable fraction of moderate or severe 
anaemia associated with infection by the different Plas-
modium species. For the purposes of this study, a hae-
moglobin concentration of 7 g/dL was chosen a priori as 
an appropriate distinction between mild and moderate 
or severe anaemia (as recommended by Snow and col-
leagues [7]).
Tests for trend were done using the ptrend module 
for STATA. Univariable linear regression of continu-
ous haemoglobin data was performed for the following 
exposures: Plasmodium species (P. falciparum, P. vivax 
and mixed P. falciparum/P. vivax species infections), age 
group (<1 year, 1 to <5 years, 5 to <15 years, ≥15 years), 
self-reported ethnicity (non-Papuan, Highland Papuan, 
Lowland Papuan), pregnancy status, weight for age/
gender/ethnicity (≥survey mean,  <survey mean) and 
household income per person (>75th centile, 25th–75th 
centile,  <25th centile). Weight for age/gender/ethnicity 
was established by creating a nomogram from the survey 
data.
Multivariable linear and logistic regression analyses of 
the effect of Plasmodium parasitaemia on absolute hae-
moglobin and odds of moderate or severe anaemia were 
done for each of the age groups as well as for the study 
population as a whole. To account for the study design, 
multivariable models were adjusted for the categori-
cal variable ‘sub-district’ and the variance–covariance 
matrices of both univariable and multivariable models 
were adjusted for within-household correlation (giving 
robust standard errors). Given the effect of menstrua-
tion on haemoglobin concentrations, the hypothesis was 
that gender would modify the relationship between age 
and anaemia. The interaction between age and a com-
posite variable incorporating gender and pregnancy sta-
tus was found to be statistically significant and therefore 
was included in multivariable models of the whole study 
population.
Adjusted population fractions of moderate-to-severe 
anaemia attributable to patent parasitaemia were calcu-
lated using the aflogit module for STATA [30]. The attrib-
utable fractions cannot be summed as the model assumes 
a mutually exclusive scenario where each risk factor is 
deemed to be the first to be eliminated [31]. Outputs can 
therefore be interpreted as the proportion of moderate 
or severe anaemia that could be prevented by addressing 
the particular factor of interest in isolation. Patients with 
Plasmodium malariae infections were excluded from all 
regression models due to small numbers.
Results
Parasitaemia
In total, 5255 individuals resided in the 825 house-
holds surveyed of whom 3890 (74  %) were present and 
consented to providing a finger-prick sample of blood 
(Fig.  1). Those who either declined to provide a sample 
or were not present at the time of survey were an average 
of 4 years older (24.7 vs 20.6 years) and more likely to be 
male (71.2 vs 48.2  %) than their counterparts who pro-
vided blood samples. Patent parasitaemia was detected in 
17.0 % of the participants, with P. falciparum present in 
8.1  % (n =  315), P. vivax in 6.4  % (n =  250) and mixed 
infections in 1.9 % (n = 72) (Table 1). A history of fever 
in the preceding 24 h was present in 33.3 % (105/315) of 
those with P. falciparum, 29.2  % (73/250) with P. vivax 
and 34.7  % (25/72) with mixed infections. More infants 
(<1 year) and children between the ages of 1 and under 
5 years were infected with P. vivax compared to P. falci-
parum [12 vs five infants (p = 0.09) and 62 vs 50 children 
(1 to <5 years (p = 0.3)), respectively] whereas the oppo-
site was observed for all other age groups. After infancy, 
there was a statistically significant trend to decreasing 
prevalence of P. vivax parasitaemia with increasing age 
(p  =  0.003 for trend) but no such trend for P. falcipa-
rum (p = 0.13). Unlike in highly endemic regions, there 
was no age-associated decrease in the likelihood of hav-
ing concomitant fever with parasitaemia for either spe-
cies (p = 0.55 for P. vivax and p = 0.92 for P. falciparum). 
Overall, a higher proportion of Highland and Lowland 
Papuans were parasitized (21.2 and 17.3 %, respectively) 
than non-Papuans (13.1  %; p  <  0.001 and p  =  0.01, 
respectively).
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Anaemia
The mean haemoglobin in the sample as a whole was 
11.0 g/dL (95 % reference range 6.1–15.9 g/dL) (Table 2) 
with 5.7  % of individuals having a concentration less 
than 7 g/dL (222/3890). Presence of patent parasitaemia 
shifted the haemoglobin distribution curve markedly 
to the left and was associated with a bimodal pattern of 
haemoglobin concentrations with peaks at 9 and 10.5 g/
dL (Fig.  2). Indigenous Papuans and females had sig-
nificantly lower haemoglobin concentrations than their 
counterparts in univariable analyses while mean hae-
moglobin increased with increasing age up to 15  years. 
No correlation existed between haemoglobin and loge 
parasite density for P. falciparum [Pearson’s correlation 
coefficient (r)  =  −0.08, n  =  290, 95  % CI −0.19, 0.04, 
p = 0.2] whereas for P. vivax there was a weak negative 
Fig. 1 Population structure of those who provided a blood sample by age, gender and presence of parasitaemia
Table 1 Demographic features of participants in the household survey for whom blood samples were available
Totals include the small number of individuals with pure P. malariae infections
N (%) Gender Age group (years) Ethnicity All
Male Female 
not  
pregnant
Female 
pregnant
<1 1–5 5–15 >15 Non‑
Papuan
Highland 
Papuan
Lowland 
Papuan
Malaria 
slide 
negative
1530 (81.6) 1625 (84.2) 74 (85.1) 159 (89.8) 507 (79.0) 668 (81.4) 1895 (84.2) 1582 (86.8) 813 (77.9) 834 (81.5) 3229 (83.0)
P. falcipa-
rum
166 (8.9) 142 (7.4) 7 (8.0) 5 (2.8) 50 (7.8) 70 (8.5) 190 (8.4) 117 (6.4) 106 (10.2) 92 (9.0) 315 (8.1)
P. vivax 122 (6.5) 122 (6.3) 6 (6.9) 12 (6.8) 62 (9.7) 52 (6.3) 124 (5.5) 103 (5.7) 93 (8.9) 54 (5.3) 250 (6.4)
P. malariae 13 (0.7) 11 (0.6) 0 (0) 0 (0) 3 (0.5) 11 (1.3) 10 (0.4) 3 (0.2) 9 (0.9) 12 (1.2) 24 (0.6)
Mixed  
species
43 (2.3) 29 (1.5) 0 (0) 1 (0.6) 20 (3.1) 20 (2.4) 31 (1.4) 18 (1.0) 23 (2.2) 31 (3.0) 72 (1.9)
Total 1874 (48.2) 1929 (95.7) 87 (4.3) 177 (4.6) 642 (16.5) 821 (21.1) 2250 (57.8) 1823 (46.9) 1044 (26.8) 1023 (26.3) 3890 (100)
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correlation (r = −0.24, n = 248, 95 % CI −0.35, −0.12, 
p < 0.001). Those with parasitaemia and fever within the 
last 24 h (n = 205) had similar mean haemoglobin con-
centrations as parasitaemic individuals without fever 
(n = 456) (mean haemoglobin 9.85 vs 9.93 g/dL, p = 0.4). 
Forty-two per cent (1629/3890) of the survey participants 
had a history of fever in the last month and these indi-
viduals had both a significantly lower mean haemoglobin 
concentration and an increased unadjusted odds ratio for 
moderate or severe anaemia compared to those without a 
history of fever (mean haemoglobin concentration, 10.6 
vs 11.3 g/dL, p < 0.001, odds ratio for moderate or severe 
anaemia, 1.7, 95 % CI 1.3, 2.5, p < 0.001).
After adjusting for age, gender, ethnicity, pregnancy, 
and weight for age/gender/ethnicity, presence of P. fal-
ciparum parasitaemia was associated with an absolute 
reduction in haemoglobin of 1.16  g/dL (95  % CI 0.91, 
1.41, p < 0.001) (Table 3). The corresponding values for P. 
vivax and mixed infections were 0.66 g/dL (95 % CI 0.35, 
0.96) and 1.25 g/dL (0.71, 1.80), respectively (p < 0.001 for 
both). Although numbers were small, P. vivax was asso-
ciated with a large mean reduction in haemoglobin of 
1.93 g/dL (95 % CI 0.96, 2.89, p < 0.001) in infants. There 
was a smaller and non-statistically significant reduction 
for infants with P. falciparum (mean reduction = 0.66 g/
dL, 95 % CI −0.86, 2.18, p = 0.4).
Table 4 shows adjusted odds ratios for having haemo-
globin less than 7 g/dL. Individuals with mixed infections 
were most likely to have moderate or severe anaemia 
[Adjusted Odds Ratio (AOR) = 3.18, 95 % CI 1.67, 6.07, 
p  <  0.001] followed by patients with P. falciparum 
(AOR = 2.29, 95 % CI 1.52, 3.44, p < 0.001) and P. vivax, 
respectively (AOR = 1.93, 95 % CI 1.14, 3.25, p = 0.01). 
For infants with P. vivax the AOR was 47.7 (95 % CI 3.19, 
712, p = 0.005) and for infants with P. falciparum it was 
6.02 (95 % CI 0.54, 67.0, p = 0.1).
Population‑attributable fractions of anaemia due 
to malaria
Patent parasitaemia due to any species of Plasmo-
dium was responsible for 16.7  % (95  % CI 8.52, 24.2  %) 
of cases of moderate or severe anaemia in this study 
(Table 5). The corresponding values for P. falciparum, P. 
vivax and mixed infections were 8.35  % (95  % CI 3.25, 
13.2 %), 4.94 % (95 % CI 0.18, 9.48 %) and 3.41 % (95 % 
CI 0.08, 5.95  %), respectively. The attributable fraction 
was greatest in infants (34.4  %, 95  % CI −3.30, 58.3  %) 
and decreased with increasing age thenceforth. Plasmo-
dium vivax was responsible for greater than three times 
the proportion of moderate or severe anaemia in infants 
compared with P. falciparum [27.6  % (95  % CI −3.20, 
49.2 %) versus 7.94 % (−5.87, 20.0 %)] although the preci-
sion of these estimates was poor. Figure 3 indicates that 
in general, a greater proportion of moderate or severe 
anaemia (haemoglobin <7 g/dL) is attributable to malaria 
than mild anaemia (haemoglobin <11 g/dL).
Discussion
Despite comparatively low-level endemicity, patent para-
sitaemia in southern Papua is associated with 17 % of all 
haemoglobin concentrations under 7 g/dL. In infants and 
young children, the corresponding proportions rise to 34 
and 23 %, respectively. Although P. vivax is less prevalent 
than P. falciparum overall, this study has shown that in 
Mimika District it is the commoner species in children 
under 5 years of age and that it is associated with a higher 
population-attributable fraction of anaemia in infants. 
This study also suggests that mixed species infections are 
associated with a greater reduction in haemoglobin than 
P. falciparum or P. vivax infections alone.
Table 2 Haemoglobin by  presence of  parasitaemia 
(regardless of  presence of  symptoms) and  demographic 
characteristics
Hb haemoglobin, Std dev standard deviation, n number, coef linear regression 
coefficient, 95 % CI 95 % confidence interval
N Mean Hb Std dev Coef (95 % CI)
Plasmodium species
 Negative 3229 11.2 2.41 0
 P. falciparum 315 9.8 2.43 −1.38 (−1.67, −1.09)
 P. vivax 250 10.2 2.58 −0.99 (−1.33, −0.65)
 P. malariae 24 8.9 2.42 –
 Mixed infection 72 9.4 2.65 −1.84 (−2.52, −1.17)
Gender and pregnancy status
 Male 1874 11.4 2.70 0.85 (0.69, 1.00)
 Female non-preg-
nant
1929 10.6 2.18 0
 Female pregnant 87 10.1 1.86 −0.47 (−0.88, −0.07)
Ethnicity
 Non-Papuan 1823 11.9 2.27 0
 Highland Papuan 1044 10.0 2.48 −1.82 (−2.06, −1.58)
 Lowland Papuan 1023 10.5 2.32 −1.35 (−1.58, −1.12)
Age (years)
 <1 177 9.4 1.64 −2.35 (−2.63, −2.07)
 1–5 642 9.8 1.98 −1.91 (−2.09, −1.72)
 5–15 821 10.4 2.03 −1.29 (−1.47, −1.10)
 >15 2250 11.7 2.56 0
Weight for age/gender/ethnicity
 ≥Mean 1809 11.2 2.47 0
 <Mean 2081 10.8 2.47 −0.42 (−0.59, −0.25)
Household income per person
 >75th centile 823 11.3 2.35 0.14 (−0.13, 0.40)
 25th–75th centile 1776 11.2 2.51 0
 <25th centile 974 10.7 2.43 −0.46 (−0.74, −0.18)
 All 3890 11.0 2.48 –
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In this survey, 17  % of individuals were parasitaemic 
and approximately one-third of these were febrile. Pres-
ence of fever did not confer a greater risk of anaemia. 
Although parasitaemia was strongly associated with 
anaemia, the population attributable fractions presented 
are still likely to represent under-estimates of the true 
total effect of malaria on haemoglobin concentrations 
in the community. Full haematological recovery takes 
several weeks following acute malaria [32] suggest-
ing that many aparasitaemic individuals may have been 
experiencing the haematological after-effects of recent 
malaria infection. Nearly a half of the survey participants 
had a history of fever in the preceding month and these 
individuals had significantly lower haemoglobin concen-
trations than those without a history of fever. Since 35 % 
of fevers in the community are estimated to be due to 
Fig. 2 Frequency distribution of haemoglobin concentrations by presence of parasitaemia
Table 3 Multiple linear regression showing the effect of Plasmodium parasitaemia on mean haemoglobin concentration 
(g/dL)
Coef coefficient, 95 % CI 95 % confidence interval
a Models also include gender, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/gender/ethnicity (<mean, ≥mean)
b Models also include gender, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/gender/ethnicity (<mean, ≥mean) and pregnancy 
status
c Model also includes age (as a continuous variable) by gender/pregnancy status, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/
gender/ethnicity (<mean, ≥mean)
<1 yeara 1–5 yearsa 5–15 yearsa >15 yearsb Allc
Coef (95 % CI) p Coef (95 % CI) p Coef (95 % CI) p Coef (95 % CI) p Coef (95 % CI) p
Malaria
 Negative 0 0 0 0 0
 All species −1.35 (−2.24, 
−0.46)
0.003 −1.27 (−1.65, 
−0.89)
<0.001 −1.08 (−1.45, 
−0.70)
<0.001 −1.08 (−1.36, 
−0.80)
<0.001 −0.97 (−1.18, 
−0.77)
<0.001
 P. falcipa-
rum
−0.66 (−2.18, 
0.86)
0.4 −1.60 (−2.07, 
−1.12)
<0.001 −1.40 (−1.90, 
−0.89)
<0.001 −1.27 (−1.60, 
−0.94)
<0.001 −1.16 (−1.41, 
−0.91)
<0.001
 P. vivax −1.93 (−2.89, 
−0.96)
<0.001 −0.83 (−1.33, 
−0.33)
0.001 −0.38 (−0.91, 
0.14)
0.2 −0.78 (−1.23, 
−0.32)
0.001 −0.66 (−0.96, 
−0.35
<0.001
 Mixed 1.60 (1.01,2.19) <0.001 −1.87 (−2.88, 
−0.85)
<0.001 −1.82 (−2.39, 
−1.26)
<0.001 −1.14 (−2.04, 
−0.25)
0.01 −1.25 (−1.80, 
−0.71)
<0.001
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malaria, parasitaemia is likely to have been responsible 
for a sizeable, but unmeasured, proportion of all reduced 
haemoglobin concentrations in the aparasitaemic group.
The estimated adjusted population-attributable frac-
tions of moderate or severe anaemia in infants were 
based on small numbers. Nevertheless, the finding that 
P. vivax accounts for a greater fraction of anaemia than 
P. falciparum is in agreement with results from the local 
hospital [1, 19, 33] as well as a previous cross-sectional 
survey in Papua New Guinea [34]. At the hospital, P. 
vivax is the most common cause of malaria-related 
admission in the first year of life and produces an equal 
or greater reduction in haemoglobin than P. falciparum 
[1, 19, 33]. Others have also observed that morbidity 
from vivax malaria is maximal at a much younger age 
than falciparum malaria [35–38], a phenomenon that 
Maitland and colleagues speculate is due to greater ease 
of transmission and more rapid acquisition of immunity 
[39]. In keeping with this hypothesis, it is the authors’ 
view that both the greater prevalence of vivax malaria 
and the severity of the associated anaemia in infancy 
observed in this study are not chance findings but are 
related to multiple relapses causing repetitive insults to 
the haematological system and inducing early develop-
ment of immunity. Two sources of evidence from this 
study support this hypothesis. First, there was a statisti-
cally significant reduction in the prevalence of P. vivax 
parasitaemia with age, whereas there was no such reduc-
tion for P. falciparum. Second, infants with P. vivax 
parasitaemia in this study had had significantly more 
episodes of fever in the last month than infants with P. 
falciparum (median 1 vs 0 episodes, p = 0.007). The sub-
sequent decline in the fraction of anaemia attributable 
to either species of Plasmodium with increasing age is 
likely to relate to three main factors: the acquisition of 
some degree of immunity, especially in the case of vivax 
malaria, the increasing importance of alternative causes 
of anaemia, such as intestinal helminthiasis and chronic 
infections, and lastly the increasing likelihood that lack 
of parasitaemia represents a state of remission or a 
period between primary infections rather than a state of 
complete malaria naivety.
Table 4 Adjusted odds ratios for having a haemoglobin concentration less than 7 g/dL
AOR adjusted odds ratio, 95 % CI 95 % confidence interval
a Models also include gender, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/gender/ethnicity (<mean, ≥mean)
b Models also include gender, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/gender/ethnicity (<mean, ≥mean) and pregnancy 
status
c Model also includes age (as a continuous variable) by gender/pregnancy status, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/
gender/ethnicity (<mean, ≥mean)
<1 yeara 1–5 yearsa 5–15 yearsa >15 yearsb Allc
AOR (95 % CI) p AOR (95 % CI) p AOR (95 % CI) p AOR (95 % CI) p AOR (95 % CI) p
Parasite negative 1 1 1 1 1
 Any species 12.7 (2.36, 68.8) 0.003 2.26 (1.12, 4.59) 0.02 2.47 (1.22, 5.01) 0.01 2.01 (1.20, 3.35) 0.008 2.25 (1.61, 3.15) <0.001
 P. falciparum 6.02 (0.54, 67.0) 0.1 2.64 (1.11, 6.26) 0.03 3.02 (1.23, 7.42) 0.02 1.08 (0.95, 3.44) 0.07 2.29 (1.52, 3.44) <0.001
 P. vivax 47.7 (3.19, 712) 0.005 1.37 (0.48, 3.77) 0.5 1.84 (0.62, 5.49) 0.3 2.12 (0.93, 4.82) 0.07 1.93 (1.14, 3.25) 0.01
 Mixed species – 4.46 (1.49, 13.3) 0.008 2.11 (0.46, 9.62) 0.3 2.87 (0.64, 12.9) 0.2 3.18 (1.67, 6.07) <0.001
Table 5 Adjusted population-attributable fractions of  moderate or severe anaemia (haemoglobin concentration less 
than 7 g/dL) by presence or absence of Plasmodium parasitaemia
aPAF adjusted population-attributable fraction, 95 % CI 95 % confidence interval
a Models also include gender, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/gender/ethnicity (<mean, ≥mean)
b Models also include gender, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/gender/ethnicity (<mean, ≥mean) and pregnancy 
status
c Model also includes age (as a continuous variable) by gender/pregnancy status, ethnicity (non-Papuan, Highland Papuan, Lowland Papuan) and weight for age/
gender/ethnicity (<mean, ≥mean)
<1 yeara 1–5 yearsa 5–15 yearsa >15 yearsb Allc
aPAF 95 % CI aPAF 95 % CI aPAF 95 % CI aPAF 95 % CI aPAF 95 % CI
Any species 34.4 −3.30, 58.3 23.2 3.34, 39.0 19.4 0.99, 34.5 12.1 1.80, 21.4 16.7 8.52, 24.2
P. falciparum 7.94 −5.87, 20.0 10.5 −0.66, 20.5 13.7 0.04, 25.5 5.34 −1.69, 11.9 8.35 3.25, 13.2
P. vivax 27.6 −3.20, 49.2 4.07 −6.21, 13.4 4.28 −4.90, 12.7 4.16 −2.14, 10.1 4.94 0.18, 9.48
Mixed species – 8.55 1.93, 14.7 1.99 −3.08, 6.82 1.80 −1.91, 5.37 3.41 0.08, 5.95
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This study showed that mixed species infections were 
associated with a greater drop in haemoglobin and a 
higher risk of moderate or severe anaemia than infec-
tions with P. falciparum or P. vivax alone. This finding is 
consistent with other work from Papua [1, 19] and Papua 
New Guinea [40] but in direct contradiction to research 
carried out in Thailand and elsewhere [39]. Concomitant 
infection with P. vivax in northern Thailand has been 
postulated to attenuate the risk of severe anaemia sec-
ondary to P. falciparum infection, possibly due to some 
degree of cross-species immunity [32, 39]. In Papua, 
where endemicity of both species is higher, mixed infec-
tion may reflect a greater likelihood of having had mul-
tiple recent malaria infections (likely due to P. vivax), 
driving deeper levels of anaemia.
This study has several limitations. Due to the cross-
sectional design it was not possible to draw solid conclu-
sions about the direction of the observed associations. 
Although anaemia is an established sequel of both fal-
ciparum and vivax malaria, there is evidence that iron 
deficiency anaemia reduces the risk of falciparum malaria 
[41] and conversely, that administering iron supplements 
to iron-replete individuals may slightly increase the risk 
[42, 43]. The comparative effect of this reverse causation 
is likely to be small since there were no special commu-
nity-wide supplementation programmes at the time of 
the survey.
The population-attributable fractions were estimated 
using odds ratios as approximations of relative risk. Since 
moderate or severe anaemia was not a particularly rare 
outcome, this may have resulted in slight overestimation 
of the attributable fractions, particularly for 1–5  years 
olds who had a prevalence of moderate or severe anaemia 
of 9.4 %.
Selection bias may have affected the population-
attributable fractions due to their heavy reliance on the 
prevalence of parasitaemia in the sample. Those who did 
not provide a blood sample (mostly due to absence at 
the time of the survey) tended to be older males. Over-
all, there was relatively little effect of increasing age or 
gender on the odds of parasitaemia, however those who 
did not provide a blood sample could conceivably have 
been at greater risk of malaria acquisition due to behav-
ioural or lifestyle factors. If this were true, the frac-
tion of anaemia attributable to malaria may have been 
underestimated.
Several potentially important confounders could not 
be controlled for in analyses. Infestation with intestinal 
helminths has been shown to cause an additive reduction 
in haemoglobin concentrations in malaria co-infected 
children [44]. Although there is a great deal of geospatial 
overlap between malaria and intestinal helminths [45], 
the immunological relationship remains less clear [46, 
47]. Two studies by Nacher and Spiegel, respectively, sug-
gest that the presence of intestinal helminths increases 
the risk of falciparum malaria by a factor of between 1.5 
and 2.2 [48, 49]. Even if this is the case, the results of this 
study for infants and children under 5 years are unlikely 
to be significantly confounded since intestinal helminth 
density does not typically peak until early adulthood 
Fig. 3 Proportion of participants with haemoglobin concentrations <11 and <7 g/dL who had parasitaemia (bar labels = absolute numbers)
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and a previous study showed minimal impact of intesti-
nal helminthiasis on haemoglobin concentrations before 
30 months of age [50].
Haemoglobin and red cell abnormalities as a whole are 
protective against severe malarial anaemia [51–53] but 
their effect on the risk of uncomplicated Plasmodium 
infection is less clear and may differ between species [51, 
54, 55]. Since these disorders are themselves risk factors 
for anaemia, differences in their distribution between 
participants with and without parasitaemia could poten-
tially have confounded the models.
Incorporating weight for age/gender/ethnicity into the 
multivariable regression models should have accounted 
for at least some of the potential confounding caused by 
iron deficiency anaemia. Since iron deficiency is thought 
to be protective against Plasmodium infection, any 
residual confounding is likely to have biased the results 
towards the null. Finally, the effects of chronic disease 
and bacteraemia could not be controlled for in this analy-
sis. The former is unlikely to have been important in the 
younger age groups and bacteraemia would be expected 
to be rare in the community setting.
Conclusions
Despite comparatively low-level Plasmodium endemicity, 
patent parasitaemia (whether symptomatic or not) is an 
important and preventable cause of anaemia in southern 
Papua. Young children bear the brunt of this burden but 
the haematological effects also extend into adulthood. 
Plasmodium vivax is an especially important cause of 
anaemia in infants, probably because it causes recurrent 
disease prior to the onset of immunity. Since infancy is 
a time of increased susceptibility to infectious diseases 
as well as rapid physical and neurological development, 
anaemia associated with vivax malaria may be an impor-
tant and under-estimated contributor to indirect malaria 
mortality and developmental morbidity in regions where 
this species is prevalent.
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